Literature DB >> 21607393

Origin of heterogeneity of interleukin-6 (IL-6) levels in malignant pleural effusions.

A Yokoyama, N Kohno, S Fujino, H Hamada, Y Inoue, S Fujioka, K Hiwada.   

Abstract

We measured interleukin-6 (IL-6) concentrations from 48 malignant pleural effusions by an enzyme immunoassay and found a marked heterogeneity of the concentrations. The histological type of the malignant cells and total counts or differentials of the cells in effusions could not account for the heterogeneity. We newly established five malignant cell lines and found that the amounts of IL-6 produced by them were well correlated with IL-6 concentrations of the effusions from which these lines were derived (r=0.96; p<0.01). These results suggest that a marked heterogeneity of IL-6 concentrations in malignant effusions reflects the differential production of IL-6 by malignant cells in pleural space.

Entities:  

Year:  1994        PMID: 21607393     DOI: 10.3892/or.1.3.507

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  EGCG induces human mesothelioma cell death by inducing reactive oxygen species and autophagy.

Authors:  Motohiko Satoh; Yukitoshi Takemura; Hironobu Hamada; Yoshitaka Sekido; Shunichiro Kubota
Journal:  Cancer Cell Int       Date:  2013-02-23       Impact factor: 5.722

2.  In vitro and in vivo anti-tumor activity of alectinib in tumor cells with NCOA4-RET.

Authors:  Sachiko Arai; Kenji Kita; Azusa Tanimoto; Shinji Takeuchi; Koji Fukuda; Hiroshi Sato; Seiji Yano
Journal:  Oncotarget       Date:  2017-05-16

3.  Antitumor activity of MEK and PI3K inhibitors against malignant pleural mesothelioma cells in vitro and in vivo.

Authors:  Seigo Miyoshi; Hironobu Hamada; Naohiko Hamaguchi; Aki Kato; Hitoshi Katayama; Kazunori Irifune; Ryoji Ito; Tatsuhiko Miyazaki; Takafumi Okura; Jitsuo Higaki
Journal:  Int J Oncol       Date:  2012-05-08       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.